- Study: Corn genes boost switchgrass-to-fuel process
Researchers from the University of California, Berkeley, have discovered that the addition of "mutant" corn genes could boost the starch content in switchgrass and make it easier to process into cellulosic ethanol, according to a report in the Proceedings of the National Academy of Sciences. "Having extra starch may minimize the need for extensive pretreatment" because starch "is much easier to digest compared with cellulose," the researchers said. The biotech switchgrass didn't flower even after growing for two years, reducing the chance of "trans-gene flow into native plant species," the researchers said. Bloomberg (10/10)        - Chancellor wants to turn USCF into a health sciences innovator
As the chancellor of the University of California, San Francisco, Dr. Susan Desmond-Hellmann says she wants to transform the university into "the world's pre-eminent health sciences innovator" that can quickly translate research into treatments, provide patients with "unparalleled" care and retain first-rate faculty and staff. Desmond-Hellmann, who served as president of product development at Genentech, said she hoped the university would boost its partnerships with biotech firms in the Bay Area to generate more money in addition to grants, tuition and patient fees being collected by the university. The New York Times (tiered subscription model) (10/10) - Roche compound shows early promise against Alzheimer's plaques
A small Phase I trial, published in the Archives of Neurology, showed that Roche Holding's investigational treatment gantenerumab clears amyloid plaques in the brain of patients with Alzheimer's disease. The drugmaker is preparing to launch a midstage study to examine whether gantenerumab improves memory recall and daily life. Roche aims "not only to demonstrate the effects of gantenerumab on brain amyloid but also to start elucidating its mechanism of action," said official Luca Santarelli. Fox Business/Dow Jones Newswires (10/10)  | FREE TRIAL – Thomson Reuters Cortellis™ Pipeline Intelligence
Discover new opportunities in drug development and licensing faster. Cortellis gives you an innovative way of finding and acting on drug pipelines, deals, patents, companies, breaking industry news, and conference coverage in one source, intuitively presented.
Click here to see if you qualify for a free trial! |
  | LET’S GO DESIGN: Episode #5
In this episode of SolidWorks’ interactive web series, Jeremy moves closer to the final design of our Hot Rod Baby Buggy and also hot-wires the golf cart motor to show how the aluminum tracks perform flawlessly. Watch at LetsGoDesign.tv. |
 - Czech Republic aims to establish research institute
Efforts to establish the Central European Institute of Technology in Brno, Czech Republic, started last week. The institute will feature facilities for proteomics, nanotechnology and molecular and functional imaging, among others. Its research focus will encompass human molecular medicine. GenomeWeb Daily News (10/7)  | Make your business phone system decision much easier. Not sure what your buyer type is? Need a better understanding of the features available? Download this free guide to get access to Focus' Short List as well as our side-by-side assessment of all of the key vendors in the space. |
| News from BIO |  |  | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the monthly BIOtechNOW e-newsletter.
| SmartQuote | | | |  | The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man."
--George Bernard Shaw,
Irish playwright  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, October 10, 2011
- Friday, October 07, 2011
- Thursday, October 06, 2011
- Wednesday, October 05, 2011
- Tuesday, October 04, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment